Viewing Study NCT06388694



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06388694
Status: COMPLETED
Last Update Posted: 2024-04-29
First Post: 2024-04-22

Brief Title: Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests
Sponsor: Kaiser Permanente
Organization: Kaiser Permanente

Study Overview

Official Title: Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests A Randomized Clinical Trial
Status: COMPLETED
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This cluster randomized trial will compare pharmacist management of secure message requests for refills of attention deficit hyperactivity medications with primary care physician management regarding quality of care timeliness of service and parent care experience
Detailed Description: Importance Enhancing the management of messages from patients and providing high-quality consistent care are top priorities for The Permanente Medical Group TPMG and Kaiser Foundation HospitalsHealth Plan KFHP A special extension of the Ryan Haight Act currently enables providers to prescribe controlled substances via telehealth interactions but expires in December 2024 Information about the quality of care provided via telehealth prescribing of controlled substances by pharmacists and primary care physicians would be helpful to inform care delivery within Kaiser Permanente and beyond

Objective To compare pharmacist management of secure message requests for refills of attention deficit hyperactivity disorder ADHD medications with primary care physician management regarding quality of care efficiency of service and parent satisfaction

Design setting and participants This cluster randomized clinical trial will include parents of children in Kaiser Permanente Northern California who request ADHD medication refills via secure messages from April 29 to June 28 2024 Of KPNCs 63 facilities eligible for inclusion we will assign 32 to Pharmacist Care and 31 to PCP Care

Intervention In the intervention group a regional team of pharmacists will manage ADHD medication refill requests made via secure message using a standard protocol In the comparison group primary care physicians pediatricians and family medicine physicians will manage these visits using a similar protocol

Main Outcomes and Measures The primary outcome is whether a patient who did not have a weight recorded in the 6 months before the refill request was referred for a primary care follow-up visit Secondary outcomes are the days from the secure message request to the prescription order and medication fill and parent satisfaction

Potential Results We will test the hypotheses that Pharmacist Care compared with PCP Care will have higher quality of care faster time to prescriptions and fills and higher patient satisfaction

Potential Conclusions and Relevance If pharmacist care for ADHD medication refill requests has better or similar outcomes compared with PCP care this will provide evidence supporting continuation of this approach This studys findings will be useful for KPNC and to inform discussions about renewing the special extension of the Ryan Haight Act that allows this approach

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None